"A post-antibiotic era-in which common infections and minor injuries can kill-far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century."
World Health Organization (WHO) 2014
The problem of Antimicrobial resistance (AMR) is so serious that some believe it threatens the progress and achievements of modern science. Resistance to common bacteria has already reached alarming levels in all parts of the world — and some available treatment options for common infections are becoming ineffective. AMR threatens the effective prevention and treatment of a growing range of infections, including those related to wounds, pneumonia, and urinary-tract and bloodstream conditions, whether caused by bacteria, parasites, viruses or fungi.
According to the "Antimicrobial Resistance: Global Report on Surveillance," released in April 2014, the key findings and public health impact of AMR include:
- High rates of resistance have been found in bacteria that cause common, community-acquired infections (e.g. urinary-tract infection, pneumonia) in all WHO regions.
- There are substantial gaps in disease surveillance, and a weakening of standards for methodology, data sharing and coordination.
WHO's report is the first accurate picture of the magnitude of AMR globally. The report acknowledges that resistance to common bacteria has reached alarming levels in many parts of the world and that in some settings, few, if any, of the available treatments options remain effective for common infections. AMR has a negative impact on patient outcomes and health care costs. Surveillance of antibacterial resistance must be coordinated to develop an action plan to mitigate AMR. The first steps begin with you:
- Only prescribe antibiotics when they are truly needed.
- Prescribe and dispense the right antibiotic(s) to treat the illness.
To view WHO's full report, please visit their website.